Second Opinion Statistics in US 2026 | How Often Right, Outcomes & Key Facts

What is a Medical Second Opinion?

A medical second opinion is the practice of consulting a second qualified physician or specialist to review, confirm, or challenge an initial diagnosis or treatment plan. In the United States in 2026, it is one of the most evidence-backed yet consistently underutilized tools available to patients navigating serious illness. The case for seeking a second opinion is not rooted in distrust of physicians — it is rooted in the mathematical reality of diagnostic uncertainty. Medicine is a discipline that involves judgment, interpretation, and probabilistic reasoning under conditions of incomplete information. Even the most skilled clinicians working in well-equipped institutions make diagnostic errors. The Agency for Healthcare Research and Quality (AHRQ) has estimated that at least 1 in 20 adult Americans is affected by a diagnostic error each year, and the landmark Johns Hopkins / BMJ Quality & Safety study (2023) found that diagnostic errors lead to 795,000 deaths or permanent disabilities annually in the US alone. Against that backdrop, the act of seeking a second opinion is not a luxury or an act of anxiety — it is a rational, evidence-supported patient safety strategy.

What makes second opinions in the US in 2026 a topic of growing urgency is the convergence of two trends pulling in opposite directions. On one hand, the research evidence for the value of second opinions has never been stronger — peer-reviewed data from Mayo Clinic, Cleveland Clinic, Johns Hopkins, and the AHRQ all confirm that second opinions change diagnoses or treatment plans in a substantial proportion of cases, often with major clinical and financial consequences. On the other hand, second opinions remain dramatically underutilized: nearly half of Americans never seek one, most physicians only sometimes recommend them, and systemic barriers including cost, insurance coverage gaps, and entrenched referral patterns continue to prevent patients from accessing expert review even when they want it. The global medical second opinion market — valued at $7.2 billion in 2026 and growing at a CAGR of 14.8% — reflects the rising institutional and commercial recognition of this gap, even as millions of individual patients remain unaware that second opinion programs exist.

Interesting Facts About Second Opinions in the US 2026

SECOND OPINION FAST FACTS — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
88% of Mayo Clinic referrals     ████████████████████  got new/refined diagnosis
Only 12% of diagnoses confirmed  ████                  fully confirmed at 2nd opinion
21% received completely new dx   ████████              completely different diagnosis
67% of Cleveland Clinic VSOs     █████████████████     changed diagnosis or treatment
85% avoided surgery              ████████████████████  when surgery was initially recommended
49% of Americans NEVER seek      ████████████████████  a second opinion (Gallup)
Only 28% of doctors regularly    ████████████          recommend virtual second opinions
$8,705 average patient savings   ████████████████████  per second opinion (Cleveland Clinic 2024)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: Mayo Clinic Study (ScienceDaily); The Clinic by Cleveland Clinic / Vital Statistics Online VSO Analysis, BusinessWire March 2024; Gallup Poll national survey (~5,000 Americans); Patient Safety & Quality Healthcare / The Clinic Survey, June 2025; PubMed Systematic Review NCBI (PMID 24797646); DataM Intelligence Medical Second Opinion Market Report 2026

The headline statistic from this table is one that should appear in every patient rights brochure in every US hospital: only 12% of patients who sought a second opinion at Mayo Clinic had their original diagnosis fully confirmed. That means 88% of referral patients — nearly 9 out of every 10 — walked away with either a refined understanding of their condition or an entirely different diagnosis than what they had been given. 21% received a completely changed diagnosis — meaning roughly 1 in 5 patients had been told something fundamentally incorrect about the most important medical decision of their lives. The fact that 49% of Americans never seek a second opinion — as documented in a Gallup poll of nearly 5,000 people — means that a substantial portion of those 1 in 5 are simply never corrected.

The Cleveland Clinic virtual second opinion (VSO) data — independently verified by research firm Vital Statistics Online in their 2024 analysis of 300 randomized patient cases — adds a financial dimension that should be equally compelling to insurers, employers, and policymakers. At an average saving of $8,705 per patient (and $100,911 for high-cost cases), virtual second opinions deliver a measurable return on investment that dwarfs their cost. For 85% of patients initially recommended for surgery, the second opinion led to a completely different treatment approach — meaning the majority of high-cost surgical recommendations in the study were either unnecessary or replaceable with less invasive options. The fact that only 28% of physicians regularly recommend virtual second opinions — despite 95% supporting them in principle — is perhaps the most actionable data point in this entire dataset.

How Often Are Second Opinions Right in the US 2026 | Diagnosis Change Rates

SECOND OPINION DIAGNOSIS CHANGE RATE — BY SETTING & INSTITUTION
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Mayo Clinic (all specialties)       ████████████████████  88% new/refined; 21% completely changed
Cleveland Clinic VSO (virtual)      █████████████████     67% diagnosis/treatment changed
2nd.MD expert platform              ████████████████████  35% alternate diagnosis
National program study (6,791 pts)  ████████████████      14.8% dx change; 37.4% treatment change
Research review (2021, 58% altered) ████████████████████  58% profoundly different outcome
NCI breast cancer MTB review        ██████████████        43% diagnosis changed
Spine MRI second opinion            █████████████████████ 61% discordant reading
Radiology (discordant → treatment)  ████████████████████  92% had treatment plans changed
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: Mayo Clinic (ScienceDaily); National Patient-Initiated Second Opinion Program (ScienceDirect); Cleveland Clinic / Vital Statistics Online BusinessWire 2024; NCBI/PMC Breast Cancer MTB Study (PMC6132422); PubMed Systematic Review NCBI (PMID 24797646); Expert Radiology January 2026 citing UW Medicine JACR 2022; HCPLive April 2026

The diagnosis change rate data in the US in 2026 reveals a consistent pattern across every institution, platform, and specialty studied: second opinions change clinical decisions at a frequency that no rational healthcare system can afford to ignore. The range of 10%–62% major changes documented in the systematic review of all published second opinion literature reflects genuine variation by condition complexity, specialty, and patient population — but even the lower bound of 10% means 1 in 10 patients getting a second opinion discovers a meaningfully different clinical picture. At the higher end, the Mayo Clinic’s 88% new-or-refined figure and NCI breast cancer center’s 43% diagnosis-change rate describe what happens when patients with complex, serious conditions reach subspecialty-level expert review.

The radiology second opinion data is especially important because imaging interpretation is embedded in virtually every significant diagnostic workup in modern medicine. A discordance rate of up to 68.9% for body MRI second opinions — and the finding that 92% of patients with discrepant radiology reads had their treatment plans changed — means that imaging misinterpretation is not a rare exception caught by second opinions, but a routine occurrence. The spine surgery data is equally striking: 61% of spine MRI second opinions disagreed with the original reading, and 75% of those disagreements recommended more conservative, less invasive management. When nearly two-thirds of patients referred for spinal surgery are told something different by a second radiologist — and three-quarters of those differences recommend avoiding surgery — the question is no longer whether second opinions are valuable. The question is why the healthcare system is not structured to make them standard practice.

Second Opinion Outcomes & Patient Savings in the US 2026

SECOND OPINION OUTCOMES & COST SAVINGS — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Average saving per patient (VSO)           $8,705   ████████████████████
High-cost case avg saving (>$10K plans)    $100,911 ████████████████████
MSK condition avg saving per patient       $28,220  ████████████████████
Cardiovascular condition avg saving        $8,036   ████████████████████
Cancer-related condition avg saving        $4,306   ████████████████████
Surgery avoided (initially recommended)    85%      ████████████████████
Hospitalizations recommended               62% less ████████████████████
Patient satisfaction with VSO              94.7%    ████████████████████
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: The Clinic by Cleveland Clinic / Vital Statistics Online, BusinessWire March 2024; National Patient-Initiated Second Opinion Program study, ScienceDirect (6,791 patients); FierceHealthcare April 2024; Becker’s Hospital Review June 2025; NCBI/PMC (PMC6132422)

The financial outcomes of second opinions in the US in 2026 make the strongest possible case for systemic adoption. The Cleveland Clinic VSO analysis — independently conducted by Vital Statistics Online across 300 randomly selected patient cases — is the most rigorous financial accounting of second opinion value currently in the published literature. At $8,705 average savings per patient, a virtual second opinion that costs under $2,000 out-of-pocket delivers a return on investment exceeding 4x on every case — and that ratio explodes to 50x+ for high-cost cases where the average saving reaches $100,911. For musculoskeletal conditions — the category driving many of the most expensive and frequently unnecessary orthopedic surgeries in the US — the $28,220 average saving per patient represents the difference between a costly surgery and rehabilitation with a far lower risk profile and complication rate.

The 94.7% patient satisfaction rate with the virtual second opinion experience — from a study of nearly 7,000 patients across medical specialties — is particularly notable because it defuses the concern that seeking a second opinion is a disruptive or uncomfortable experience. Patients are not distressed by second opinions; they are reassured by them. The finding that only 61.2% planned to follow the recommendations despite 94.7% satisfaction suggests a different problem: patients value the information but face real-world barriers — cost, logistics, established relationships with original providers — that prevent them from acting on what they learn. Closing that gap between second opinion uptake, follow-through, and outcome is one of the most consequential open problems in US patient safety in 2026.

Who Seeks Second Opinions in the US 2026 | Barriers & Disparities

WHO SEEKS (AND DOESN'T SEEK) SECOND OPINIONS — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Never seek a second opinion          49%  ████████████████████
Sometimes seek                       41%  ████████████████████
Always seek                           3%  █
Confident in doctor; didn't seek     88.7% of non-seekers  ████████████████████
Oncologists recommending VSOs        52%  █████████████████████
Other specialists recommending VSOs  28% or less  █████████
Lower SES/education → less likely    ████████████████████  documented disparity
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: Gallup Poll national survey (~5,000 Americans); NCBI/PMC PMC7374890 (oncology second opinions study); Patient Safety & Quality Healthcare / The Clinic Survey June 2025; PubMed Systematic Review (PMID 24797646); NCBI/PMC PMC6335699 (second opinion inequalities); Dartmouth Health July 2025; SNS Insider Market Research

The second opinion utilization gap in the US in 2026 is as much a problem of human psychology and structural inequality as it is a problem of awareness. The Gallup finding that 49% of Americans never seek a second opinion is consistent across multiple surveys spanning two decades — suggesting it reflects a stable cultural tendency to defer to medical authority rather than a temporary knowledge gap that can be closed with a single awareness campaign. The fact that 88.7% of cancer patients who did not pursue a second opinion cited confidence in their original doctor — not lack of awareness — as the reason, confirms that the barrier is primarily psychological and relational, not informational. Patients who trust their doctor find it emotionally difficult to initiate what can feel like a challenge to that relationship, even when the data strongly suggests they should.

The socioeconomic disparity in second opinion access documented in the NCBI literature is one of the most inequitable dimensions of this issue. Patients with lower incomes and less education are significantly less likely to seek second opinions, and physicians are less likely to proactively inform them that they have that option. Combined with the insurance barrier — health plans frequently restrict access to out-of-network specialists who might provide the most genuinely independent second review — this means that the patients who most need a corrective second opinion are systematically least likely to receive one. The August 2025 launch of subscription-based employer-sponsored second opinion packages — reported as a major product innovation in the second opinion market — represents meaningful progress for working Americans with employer health plans, but leaves the uninsured and underinsured populations entirely behind.

Second Opinion Market & Virtual Trends in the US 2026

US VIRTUAL SECOND OPINION MARKET GROWTH — 2024 TO 2033
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
North America market 2024    $1.99B  ████████
Global market 2025           $6.43B  ████████████████████
Global market 2026           $7.21B  ████████████████████
North America market 2033    $6.09B  ████████████████████
Global market 2033           $15.99B ████████████████████
CAGR (North America 2025–33) 13.3%   ████████████████
CAGR (Global 2026–33)        14.8%   ████████████████████
Oncology share of market     28.6%   █████████████████████
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Source: DataM Intelligence North America Medical Second Opinion Market Report 2026; DataM Intelligence Global Medical Second Opinion Market Report 2026; Amwell / Cleveland Clinic Becker’s Hospital Review June 2025; Open PR / DataM September 2025; Healthcare Brew April 2024

The virtual and digital second opinion market in the US in 2026 is one of the fastest-growing segments in healthcare services, and for straightforward reasons: it addresses a documented, quantified problem (diagnostic error) with a scalable, technology-enabled solution that delivers measurable financial and clinical returns. The North America market reaching $1.99 billion in 2024 — growing toward $6.09 billion by 2033 at a 13.3% CAGR — reflects rising demand from three distinct sources: individual patients navigating serious diagnoses, employers seeking cost-containment tools, and health plans looking to reduce unnecessary high-cost procedures. Oncology leads with 28.6% of market share, driven by the high stakes of cancer diagnoses, the frequency of treatment plan disagreements, and the concentration of subspecialty expertise at a small number of academic cancer centers that most patients cannot physically access.

The 2025–2026 market developments signal a structural maturation of the industry. The August 2025 launch of employer-sponsored subscription packages reflects the corporate benefits market recognizing what the Cleveland Clinic data has documented: a second opinion that costs under $2,000 and saves an average of $8,705 — or $100,911 in high-cost cases — is not a patient perk. It is a financially rational healthcare benefit. The September 2025 expansion of cross-border programs for cancer and rare disease at major hospital networks closes a critical access gap for patients in smaller markets who cannot reach academic medical centers. And the January 2026 acceleration of telehealth-integrated second opinion services — embedding expert review directly into primary care digital platforms — represents the clearest signal yet that second opinions are moving from optional addendum to embedded standard of care in US healthcare. The question in 2026 is no longer whether virtual second opinions work. It is whether the US healthcare system will build them into routine practice quickly enough to prevent the hundreds of thousands of deaths and disabilities that diagnostic error continues to cause each year.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE